PharmaSGP Holding SE provided earnings guidance for the fiscal year 2022. For the year, the company expects revenue to be between EUR 78 million to EUR 82 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.2 EUR | +0.87% | -0.85% | +3.11% |
29/04 | PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | PharmaSGP Holding SE Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.11% | 297M | |
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- PSG Stock
- News PharmaSGP Holding SE
- PharmaSGP Holding SE Provides Earnings Guidance for the Fiscal Year 2022